Date: 2018-06-04
Type of information: Nomination
Compound: chief technical officer
Company: Allogene Therapeutics (USA - CA)
Therapeutic area: Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On June 4, 2018, Allogene Therapeutics announced the appointment of Alison Moore, Ph.D. as chief technical officer overseeing product sciences, supply chain, manufacturing, quality and technical operations. Dr. Moore previously served in operations leadership roles at Amgen and Genentech.
- Dr. Moore has extensive experience in all aspects of biomanufacturing and CMC product development, working in both Operations and Research and Development. She most
recently served as Senior Vice President, Process Development at Amgen. Dr. Moore has previously held senior roles at Amgen in Operations Technology, Process and Product engineering, and Corporate Manufacturing. Prior to these positions, she was Vice President, Site Operations at Amgen's Fremont, California, manufacturing facility. Before joining Amgen, Dr. Moore was a Director in Chemistry, Manufacturing and Controls, Regulatory Affairs at Genentech.
- Dr. Moore holds a Ph.D. in Cell Biology from Manchester University, England, and a bachelor’s in Pharmacology with Honors from Manchester University, England. Following her doctoral degree work at Manchester University, she was a Postdoctoral Research Fellow at the Medical University of Lübeck, Germany, and at Genentech.
Financial terms:
Latest news:
Is general: Yes
